These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15561271)

  • 1. Allogeneic T-cell apoptosis induced by interleukin-10-modified dendritic cells: a mechanism of prolongation of intestine allograft survival?
    Zhu M; Wei MF; Liu F; Shi HF; Wang G; Chen S
    Transplant Proc; 2004 Oct; 36(8):2436-7. PubMed ID: 15561271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-10 modified dendritic cells induce allo-hyporesponsiveness and prolong small intestine allograft survival.
    Zhu M; Wei MF; Liu F; Shi HF; Wang G
    World J Gastroenterol; 2003 Nov; 9(11):2509-12. PubMed ID: 14606086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infusion of stably immature monocyte-derived dendritic cells plus CTLA4Ig modulates alloimmune reactivity in rhesus macaques.
    Zahorchak AF; Kean LS; Tokita D; Turnquist HR; Abe M; Finke J; Hamby K; Rigby MR; Larsen CP; Thomson AW
    Transplantation; 2007 Jul; 84(2):196-206. PubMed ID: 17667811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-12p40-overexpressing immature dendritic cells induce T cell hyporesponsiveness in vitro but accelerate allograft rejection in vivo: role of NK cell activation and interferon-gamma production.
    Sun W; He X; Guo Z; Wang Q; Li X; Rayner J; Zhang L; Wang J; Cao X
    Immunol Lett; 2004 Jul; 94(3):191-9. PubMed ID: 15275966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immature rat myeloid dendritic cells generated in low-dose granulocyte macrophage-colony stimulating factor prolong donor-specific rat cardiac allograft survival.
    DePaz HA; Oluwole OO; Adeyeri AO; Witkowski P; Jin MX; Hardy MA; Oluwole SF
    Transplantation; 2003 Feb; 75(4):521-8. PubMed ID: 12605121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrinsic ability of GM+IL-4 but not Flt3L-induced rat dendritic cells to promote allogeneic T cell hyporesponsiveness.
    Taieb A; Breitinger JJ; Unadkat JV; Shufesky WJ; Morelli AE; Thomson AW; Lee WP; Feili-Hariri M
    Clin Immunol; 2007 May; 123(2):176-89. PubMed ID: 17276735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term survival of limb allografts induced by pharmacologically conditioned, donor alloantigen-pulsed dendritic cells without maintenance immunosuppression.
    Ikeguchi R; Sacks JM; Unadkat JV; Solari M; Horibe EK; Thomson AW; Lee AW; Feili-Hariri M
    Transplantation; 2008 Jan; 85(2):237-46. PubMed ID: 18212629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Programmed death-1 signaling is essential for the skin allograft protection by alternatively activated dendritic cell infusion in mice.
    Dai H; Zhu H; Lei P; Yagita H; Liu J; Wen X; Zhou W; Gong F; Shen G; Fang M
    Transplantation; 2009 Oct; 88(7):864-73. PubMed ID: 19935456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of donor-specific T-cell hyporesponsiveness using dexamethasone-treated dendritic cells in two fully mismatched rat kidney transplantation models.
    Stax AM; Gelderman KA; Schlagwein N; Essers MC; Kamerling SW; Woltman AM; van Kooten C
    Transplantation; 2008 Nov; 86(9):1275-82. PubMed ID: 19005410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolongation of rat intestinal allograft survival by administration of triptolide-modified donor bone marrow-derived dendritic cells.
    Chen T; Xu H; Wang HQ; Zhao Y; Zhu CF; Zhang YH; Ji MJ; Hua YB; Wu WX
    Transplant Proc; 2008 Dec; 40(10):3711-3. PubMed ID: 19100471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation.
    Kuo YR; Huang CW; Goto S; Wang CT; Hsu LW; Lin YC; Yang KD; Chen CL; Lee WP
    J Surg Res; 2009 May; 153(2):317-25. PubMed ID: 19101689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cells genetically engineered to express IL-4 exhibit enhanced IL-12p70 production in response to CD40 ligation and accelerate organ allograft rejection.
    Kaneko K; Wang Z; Kim SH; Morelli AE; Robbins PD; Thomson AW
    Gene Ther; 2003 Jan; 10(2):143-52. PubMed ID: 12571643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of interleukin-12p40 gene transfer on rat corneal allograft survival.
    Ritter T; Yang J; Dannowski H; Vogt K; Volk HD; Pleyer U
    Transpl Immunol; 2007 Nov; 18(2):101-7. PubMed ID: 18005852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolongation of skin graft survival by modulation of the alloimmune response with alternatively activated dendritic cells.
    Roelen DL; Schuurhuis DH; van den Boogaardt DE; Koekkoek K; van Miert PP; van Schip JJ; Laban S; Rea D; Melief CJ; Offringa R; Ossendorp F; Claas FH
    Transplantation; 2003 Dec; 76(11):1608-15. PubMed ID: 14702533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF-beta(1) gene modified immature dendritic cells exhibit enhanced tolerogenicity but induce allograft fibrosis in vivo.
    Sun W; Wang Q; Zhang L; Pan J; Zhang M; Lu G; Yao H; Wang J; Cao X
    J Mol Med (Berl); 2002 Aug; 80(8):514-23. PubMed ID: 12185452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination treatment with donor interleukin-12p35 silenced dendritic cells and cyclosporine induces long-term survival of intestinal allografts in rats.
    Xu H; Chen T; Wang HQ; Hua YB; Wu WW
    Transplant Proc; 2007; 39(1):286-8. PubMed ID: 17275524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cell transfected with secondary lymphoid-tissue chemokine and/or interleukin-2 gene-enhanced cytotoxicity of T-lymphocyte in human bladder tumor cell S in vitro.
    Li YG; Wang ZP; Tian JQ; Tian BQ; Rodrigues R; Shang PF; Zhang T
    Cancer Invest; 2009 Nov; 27(9):909-17. PubMed ID: 19832038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapamycin-conditioned, alloantigen-pulsed dendritic cells promote indefinite survival of vascularized skin allografts in association with T regulatory cell expansion.
    Horibe EK; Sacks J; Unadkat J; Raimondi G; Wang Z; Ikeguchi R; Marsteller D; Ferreira LM; Thomson AW; Lee WP; Feili-Hariri M
    Transpl Immunol; 2008 Feb; 18(4):307-18. PubMed ID: 18158116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of recipient-derived dendritic cells to induce donor-specific T-cell hyporesponsiveness.
    Tiao MM; Lu L; Tao R; Harnaha J; Fung JJ; Huang LT; Qian S
    Transplant Proc; 2004 Jun; 36(5):1592-4. PubMed ID: 15251391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of heart allograft acceptability associated with recruitment of CD4+CD25+ T cells in peripheral blood by recipient treatment with granulocyte colony-stimulating factor.
    Liang HL; Yi DH; Zheng QJ; Du JF; Cao YX; Yu SQ; Zhu HL
    Transplant Proc; 2008 Jun; 40(5):1604-11. PubMed ID: 18589159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.